BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21574103)

  • 21. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
    Gurzu S; Jung I
    Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
    Hernandez BY; Frierson HF; Moskaluk CA; Li YJ; Clegg L; Cote TR; McCusker ME; Hankey BF; Edwards BK; Goodman MT
    Hum Pathol; 2005 Mar; 36(3):275-81. PubMed ID: 15791572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
    Cathro HP; Stoler MH
    Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
    Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified classification for adenocarcinoma of the gastro-oesophageal junction.
    Shearer CJ; Going JJ; Neilson LJ; Stuart RC
    ANZ J Surg; 2007 Jul; 77(7):544-9. PubMed ID: 17610690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix.
    Alsaad KO; Serra S; Schmitt A; Perren A; Chetty R
    Endocr Pathol; 2007; 18(1):16-22. PubMed ID: 17652796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
    Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
    J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
    Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH
    Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
    Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
    Lyn J; Wang Y; Wang F; Shen M; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
    Luo HT; Liang CX; Luo RC; Gu WG
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.